stars 1 stars 2 stars 3

Synapse Biomedical Inc (SBI) was founded in September 2002 to commercialize the NeuRx Diaphragm Pacing System (DPS)® that has been developed over a twenty-year period at Case Western Reserve University and the University Hospitals of Cleveland. The innovative research performed at these institutions has led to significant advances in the state of the art of electrical stimulation for the treatment of chronic respiratory insufficiency. This innovation allows the technology to meet clinical needs, beyond the ability of the currently available systems, in Spinal Cord Injuries, in the diaphragm conditioning in muscular dystrophies (such as ALS) and in respiratory short-term intensive care settings.

Synapse Biomedical Questions

The Synapse Biomedical annual revenue was $5.5 million in 2026.

Anthony Ignagni is the President and CEO of Synapse Biomedical.

26 people are employed at Synapse Biomedical.

Synapse Biomedical is based in Oberlin, Ohio.

The NAICS codes for Synapse Biomedical are [339, 33].

The SIC codes for Synapse Biomedical are [38, 384].

Top Synapse Biomedical Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users